Kimberly-Clark Corporation
KMB scores 53.8 on the Conservative profile, blending a fundamental score (80% weight, emphasizing quality and stability (84% of fundamental weight)) with a machine-learning signal (20% weight) trained on 82 features across 30 years of data.
Moderate penalties (-7.2 points) reflect identified risk factors. The overall score balances these against the stock's fundamental strengths.
These features are direct inputs to the machine learning model. The model was trained on these signals alongside 100 features (including 12 momentum/technical indicators) to produce the ML percentile score.
| Stock | Score | P/E | Rev Growth | Margin | Mkt Cap |
|---|---|---|---|---|---|
| KMB | 53.8 | 22.5 | -2.1% | 9.9% | $36.8B |
| MNST | 84.4 | 46.3 | 4.9% | 20.1% | $84.6B |
| COCO | 77.4 | 43.1 | 18.2% | 11.7% | $3.3B |
| CALM | 76.7 | 3.5 | 83.2% | 27.4% | $4.1B |
| LAUR | 76.3 | 25.8 | 5.5% | 18.9% | $4.9B |
| WMT | 71.5 | 46.7 | 5.1% | 2.9% | $1.0T |
| CCEP | 68.9 | 25.1 | 11.7% | 6.9% | $49.7B |
| PSMT | 66.5 | 31.5 | 7.2% | 2.7% | $4.8B |
| COST | 66.2 | 54.6 | 8.2% | 2.9% | $441.9B |
| PEP | 65.1 | 27.6 | 2.3% | 8.8% | $230.9B |
| COKE | 64.6 | 23.1 | 3.7% | 9.2% | $16.7B |
| PRDO | 64.0 | 13.1 | 24.2% | 18.9% | $2.2B |
| SFD | 63.8 | 11.3 | -3.4% | 5.5% | $9.6B |
| OLLI | 62.5 | 31.4 | 8.0% | 8.8% | $6.7B |
| FIZZ | 61.2 | 18.6 | 0.8% | 15.6% | $3.5B |
| DLTR | 61.0 | 23.9 | 4.8% | 5.9% | $25.7B |
| Sector Average | 51.1 | 33.1 | 10.6% | -3.2% | โ |
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.
Stock is in a downtrend below the 200-day moving average. Price is below both the 50-day and 200-day SMAs, indicating sustained selling pressure.
Stage 4 downtrend โ price is below both SMA50 and SMA200 with a declining 200-day average. Capital preservation takes priority. Do not buy into a downtrend.
| Metric | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Revenue | $4.1B | $4.1B | $4.2B | $4.8B |
| Gross Profit | $1.5B | $1.5B | $1.5B | $1.7B |
| Operating Income | $507M | $621M | $592M | $769M |
| Net Income | $499M | $446M | $509M | $567M |
| EPS (Diluted) | $1.50 | $1.34 | $1.53 | $1.70 |
| Gross Margin | 35.9% | 35.7% | 35.0% | 35.8% |
| Operating Margin | 12.4% | 15.0% | 14.2% | 15.9% |
| Net Margin | 12.2% | 10.8% | 12.2% | 11.7% |
This stock has traded in a compressed range for 4 of the last 5 years (3-year range: 41%). Range-bound stocks may indicate limited upside potential. A -2.7pt penalty has been applied.
| Year | Low | High | Range | Status |
|---|---|---|---|---|
| 2021 | $125.27 | $143.37 | 13.5% | Narrow |
| 2022 | $108.74 | $145.79 | 29.1% | Moderate |
| 2023 | $116.32 | $147.87 | 23.9% | Narrow |
| 2024 | $117.67 | $149.31 | 23.7% | Narrow |
| 2025 | $99.22 | $150.45 | 41% | Wide |
Growth estimates have been dampened based on technical and fundamental signals. This is a post-hoc adjustment to prevent overly optimistic projections for stocks showing declining momentum or deteriorating fundamentals.
Scores are generated by a multi-stage ML pipeline combining fundamental analysis, ensemble predictions, and structural risk signals. All data is for research purposes only and does not constitute financial advice. Past performance does not guarantee future results.